J

Jeisys Medical Inc
KOSDAQ:287410

Watchlist Manager
Jeisys Medical Inc
KOSDAQ:287410
Watchlist
Price: 12 900 KRW 0.16% Market Closed
Market Cap: ₩976.4B

Jeisys Medical Inc
Common Stock

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Jeisys Medical Inc
Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
J
Jeisys Medical Inc
KOSDAQ:287410
Common Stock
₩7.7B
CAGR 3-Years
3%
CAGR 5-Years
78%
CAGR 10-Years
N/A
I
I Sens Inc
KOSDAQ:099190
Common Stock
₩13.9B
CAGR 3-Years
26%
CAGR 5-Years
15%
CAGR 10-Years
7%
C
Classys Inc
KOSDAQ:214150
Common Stock
₩6.6B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
N/A
W
Won Tech Co Ltd
KOSDAQ:336570
Common Stock
₩8.9B
CAGR 3-Years
152%
CAGR 5-Years
74%
CAGR 10-Years
N/A
V
Viol Co Ltd
KOSDAQ:335890
Common Stock
₩5.8B
CAGR 3-Years
1%
CAGR 5-Years
65%
CAGR 10-Years
N/A
S
Seers Technology Co Ltd
KOSDAQ:458870
Common Stock
₩6.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jeisys Medical Inc
Glance View

Market Cap
976.4B KRW
Industry
Health Care

Jeisys Medical, Inc. manufactures and develops products used by plastic surgeons, dermatologist, physicians and health professionals. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-05-08. The firm manufactures and sells skin care medical devices such as ULTRAcel Q+, POTENZA, and other products. In addition, the Company also provides consumables such as cartridges and tips.

Intrinsic Value
Not Available
J

See Also

What is Jeisys Medical Inc's Common Stock?
Common Stock
7.7B KRW

Based on the financial report for Jun 30, 2024, Jeisys Medical Inc's Common Stock amounts to 7.7B KRW.

What is Jeisys Medical Inc's Common Stock growth rate?
Common Stock CAGR 5Y
78%

Over the last year, the Common Stock growth was 1%. The average annual Common Stock growth rates for Jeisys Medical Inc have been 3% over the past three years , 78% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett